IMMT expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.933400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.592200E-01
Normal-vs-Stage2
4.982000E-01
Normal-vs-Stage3
2.740400E-01
Normal-vs-Stage4
5.024200E-01
Stage1-vs-Stage2
9.811200E-01
Stage1-vs-Stage3
4.386000E-01
Stage1-vs-Stage4
7.566400E-01
Stage2-vs-Stage3
2.387000E-01
Stage2-vs-Stage4
7.084000E-01
Stage3-vs-Stage4
3.094800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.992800E-01
Normal-vs-AfricanAmerican
6.836400E-01
Normal-vs-Asian
4.372800E-01
Caucasian-vs-AfricanAmerican
6.969600E-01
Caucasian-vs-Asian
7.557200E-01
AfricanAmerican-vs-Asian
6.099200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.101000E-01
Normal-vs-Female
4.857000E-01
Male-vs-Female
9.708600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.801700E-02
Normal-vs-Age(41-60Yrs)
7.155600E-01
Normal-vs-Age(61-80Yrs)
3.913000E-01
Normal-vs-Age(81-100Yrs)
8.900800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.394400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.553000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.571770E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.559800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.048600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.656770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.390000E-01
Normal-vs-Daily Drinker
4.209200E-01
Normal-vs-Weekly Drinker
2.240200E-01
Normal-vs-Occasional Drinker
9.876000E-01
Normal-vs-Social Drinker
5.737400E-01
Non Drinker-vs-Daily Drinker
5.921200E-01
Non Drinker-vs-Weekly Drinker
8.370600E-01
Non Drinker-vs-Occasional Drinker
5.339700E-02
Non Drinker-vs-Social Drinker
3.377600E-01
Daily Drinker-vs-Weekly Drinker
4.845000E-01
Daily Drinker-vs-Occasional Drinker
1.377570E-01
Daily Drinker-vs-Social Drinker
6.136800E-01
Weekly Drinker-vs-Occasional Drinker
5.143900E-02
Weekly Drinker-vs-Social Drinker
2.592200E-01
Occasional Drinker-vs-Social Drinker
3.557000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.759600E-01
Normal-vs-Grade 2
6.968400E-01
Normal-vs-Grade 3
6.698400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.596640E-01
Grade 1-vs-Grade 3
8.803800E-02
Grade 1-vs-Grade 4
7.759600E-01
Grade 2-vs-Grade 3
5.029800E-01
Grade 2-vs-Grade 4
6.968400E-01
Grade 3-vs-Grade 4
6.698400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.916800E-01
Normal-vs-NonDiabetic
4.522800E-01
Diabetic-vs-NonDiabetic
7.694600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.035800E-01
Normal-vs-NoPancreatitis
4.022200E-01
Pancreatitis-vs-NoPancreatitis
4.787600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.156200E-01
Normal-vs-N1
4.842400E-01
N0-vs-N1
4.164200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.949600E-01
Normal-vs-TP53-NonMutant
4.616800E-01
TP53-Mutant-vs-TP53-NonMutant
2.943800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
